ketoconazole has been researched along with tanespimycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Callery, PS; Egorin, MJ; Eiseman, JL; Musser, SM; Rosen, DM; Wolff, JH | 1 |
2 other study(ies) available for ketoconazole and tanespimycin
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
Topics: Animals; Antibiotics, Antineoplastic; Benzoquinones; Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytosol; Epoxide Hydrolases; Gas Chromatography-Mass Spectrometry; Humans; Ketoconazole; Lactams, Macrocyclic; Liver; Mice; Microsomes, Liver; Mixed Function Oxygenases; Molecular Weight; NAD; Quinones; Rifabutin; Species Specificity | 1998 |